NO and angiogenesis - PubMed (original) (raw)
Review
NO and angiogenesis
John P Cooke. Atheroscler Suppl. 2003 Dec.
Abstract
Angiogenesis requires the elaboration of endothelium-derived nitric oxide (NO). Angiogenic factors induce the release of NO from endothelial cells, which mediates a multiplicity of processes involved in angiogenesis. These NO-modulated processes include endothelial cell survival, proliferation, migration, and interaction with the extracellular matrix. Derangements of the NO synthase pathway impair angiogenesis. Accordingly, the competitive inhibitor of the NOS pathway asymmetric dimethylarginine (ADMA) acts as an endogenous inhibitor of angiogenesis. By contrast, agents which increase NO synthesis, such as low dose statins, enhance angiogenesis. Modulation of the NO synthase pathway could become a new therapeutic avenue for angiogenesis-related disorders.
Similar articles
- Angiogenesis is impaired by hypercholesterolemia: role of asymmetric dimethylarginine.
Jang JJ, Ho HK, Kwan HH, Fajardo LF, Cooke JP. Jang JJ, et al. Circulation. 2000 Sep 19;102(12):1414-9. doi: 10.1161/01.cir.102.12.1414. Circulation. 2000. PMID: 10993861 - Dimethylarginine dimethylaminohydrolase: a new therapeutic target for the modulation of nitric oxide and angiogenesis.
Singh JP. Singh JP. Curr Opin Investig Drugs. 2007 Sep;8(9):736-41. Curr Opin Investig Drugs. 2007. PMID: 17729185 Review. - Asymmetric dimethylarginine (ADMA): a key regulator of nitric oxide synthase.
Böger RH, Vallance P, Cooke JP. Böger RH, et al. Atheroscler Suppl. 2003 Dec;4(4):1-3. doi: 10.1016/s1567-5688(03)00027-8. Atheroscler Suppl. 2003. PMID: 14664896 No abstract available. - Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P.
Ziche M, Morbidelli L, Masini E, Amerini S, Granger HJ, Maggi CA, Geppetti P, Ledda F. Ziche M, et al. J Clin Invest. 1994 Nov;94(5):2036-44. doi: 10.1172/JCI117557. J Clin Invest. 1994. PMID: 7525653 Free PMC article. - ADMA: its role in vascular disease.
Cooke JP. Cooke JP. Vasc Med. 2005 Jul;10 Suppl 1:S11-7. doi: 10.1177/1358836X0501000103. Vasc Med. 2005. PMID: 16444864 Review.
Cited by
- Update on vascular endothelial Ca(2+) signalling: A tale of ion channels, pumps and transporters.
Moccia F, Berra-Romani R, Tanzi F. Moccia F, et al. World J Biol Chem. 2012 Jul 26;3(7):127-58. doi: 10.4331/wjbc.v3.i7.127. World J Biol Chem. 2012. PMID: 22905291 Free PMC article. - Pan-PPAR Agonist, Bezafibrate, Restores Angiogenesis in Hindlimb Ischemia in Normal and Diabetic Rats.
Khazaei M, Salehi E, Rashidi B. Khazaei M, et al. Int J Pept. 2012;2012:637212. doi: 10.1155/2012/637212. Epub 2012 Jun 3. Int J Pept. 2012. PMID: 22701496 Free PMC article. - Endothelial nitric oxide synthase regulates brain-derived neurotrophic factor expression and neurogenesis after stroke in mice.
Chen J, Zacharek A, Zhang C, Jiang H, Li Y, Roberts C, Lu M, Kapke A, Chopp M. Chen J, et al. J Neurosci. 2005 Mar 2;25(9):2366-75. doi: 10.1523/JNEUROSCI.5071-04.2005. J Neurosci. 2005. PMID: 15745963 Free PMC article. - Regulation of placental angiogenesis.
Chen DB, Zheng J. Chen DB, et al. Microcirculation. 2014 Jan;21(1):15-25. doi: 10.1111/micc.12093. Microcirculation. 2014. PMID: 23981199 Free PMC article. Review. - The extreme anterior domain is an essential craniofacial organizer acting through Kinin-Kallikrein signaling.
Jacox L, Sindelka R, Chen J, Rothman A, Dickinson A, Sive H. Jacox L, et al. Cell Rep. 2014 Jul 24;8(2):596-609. doi: 10.1016/j.celrep.2014.06.026. Epub 2014 Jul 17. Cell Rep. 2014. PMID: 25043181 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
- P01 AG18784/AG/NIA NIH HHS/United States
- P01AI50153/AI/NIAID NIH HHS/United States
- R01 AT/HL00204/AT/NCCIH NIH HHS/United States
- R01 HL-63685/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources